Back to search
FDAFDA · Food and drugs·Recall number D-1075-2018

Dymista (azelastine hydrochloride and fluticasone propionate) Nasal Spray, 137 mcg / 50 mcg per spray, packaged in a 23 g net fill weight, Rx only, Manufactured by: Cipla Ltd., Goa, India, M.L.,, NDC 0037-0245-23

Published August 15, 2018 · Recall initiated: July 25, 2018

Summary

FDA records drug Class II recall D-1075-2018, published August 15, 2018 and initiated July 25, 2018. Recalling firm: Mylan Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 20,780 bottles; Lot: Lot #: GA70246, GA70254, Exp 02/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of foreign substance: Potential for glass in the neck area of the glass bottles.

What to do

Voluntary: Firm initiated · Letter

Get an email if DYMISTA has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DYMISTA
Manufacturer
Mylan Pharmaceuticals Inc.
Distributor
U.S. Nationwide
Lot
Lot #: GA70246, GA70254, Exp 02/2019
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dymista (azelastine hydrochloride and fluticasone propionate) Nasal Spray, 137 mcg / 50 mcg per spray, packaged in a 23 g net fill weight, Rx only, Manufactured by: Cipla Ltd., Goa, India, M.L.,, NDC 0037-0245-23 recalled?

Yes. FDA published recall D-1075-2018 on August 15, 2018. Reported hazard: Presence of foreign substance: Potential for glass in the neck area of the glass bottles.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DYMISTA.